US Patent 11752181 Compositions and methods of treating Huntington's disease

Is a

Patent

Patent attributes

Patent Applicant

Voyager Therapeutics

Current Assignee

Voyager Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11752181

Patent Inventor Names

Dinah Wen-Yee Sah

Jochen Deckert

Markus Hossbach

Yanqun Shu

Xin Wang

Pengcheng Zhou

Jinzhao Hou

Fen Chen

Date of Patent

September 12, 2023

Patent Application Number

16611041

Date Filed

May 4, 2018

Patent Citations

‌

US Patent 7125706 Method for the production and purification of adenoviral vectors

‌

US Patent 7169612 Use of EDG2 receptor in an animal model of heart failure

‌

US Patent 7186552 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same

‌

US Patent 7198951 Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor

‌

US Patent 7223585 Viral purification methods

‌

US Patent 7235393 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues

‌

US Patent 7238526 Methods and cell line useful for production of recombinant adeno-associated viruses

‌

US Patent 7241447 Adeno-associated virus vectors and uses thereof

...

Patent Citations Received

‌

US Patent 12071625 Modulatory polynucleotides

‌

US Patent 12084659 Modulatory polynucleotides

Patent Primary Examiner

CPC Code

The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11752181 Compositions and methods of treating Huntington's disease

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11752181 Compositions and methods of treating Huntington's disease